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Identification and in vitro evaluation of lipids from sclerotia of lignosus rhinocerotis for 
antioxidant and anti-neuroinflammatory activities 
 ABSTRACT 
Lignosus rhinocerotis (Cooke) Ryvarden (Tiger milk mushroom) is traditionally used to treat 
inflammation triggered symptoms and illnesses such as cough, fever and asthma. The present 
study evaluated the in vitro antioxidant, cytotoxic and anti-neuroinflammatory activities of 
the extract and fractions of sclerotia powder of L. rhinocerotis on brain microglial (BV2) 
cells. The ethyl acetate fraction had a total phenolic content of 0.30 ± 0.11 mg GAE/g. This 
fraction had ferric reducing capacity of 61.8 ± 1.8 mg FSE/g, ABTS+ scavenging activity of 
36.8 ± 1.8 mg TE/g and DPPH free radical scavenging activity of 21.8% ± 0.7. At doses 
ranging from 0.1 μg/mL - 100 μg/mL, the extract and fractions were not cytotoxic to BV2 
cells. At 100 μg/mL, the crude hydroethanolic extract and the ethyl acetate fraction elicited 
the highest nitric oxide reduction activities of 68.7% and 58.2%, respectively. Linoleic and 
oleic acids were the major lipid constituents in the ethyl acetate fraction based on FID and 
GC-MS analysis. Linoleic acid reduced nitric oxide production and down regulated the 
expression of neuroinflammatory iNOS and COX2 genes in BV2 cells.  
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